7301 Stock Overview
Engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Flora Growth Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.11 |
| 52 Week High | US$1.24 |
| 52 Week Low | US$0.76 |
| Beta | 1.8 |
| 11 Month Change | 18.72% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 11.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7301 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | -10.5% | 5.4% | 4.5% |
| 1Y | n/a | 10.2% | 13.4% |
Return vs Industry: Insufficient data to determine how 7301 performed against the German Personal Products industry.
Return vs Market: Insufficient data to determine how 7301 performed against the German Market.
Price Volatility
| 7301 volatility | |
|---|---|
| 7301 Average Weekly Movement | 15.9% |
| Personal Products Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7301's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 7301's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 103 | Clifford Starke | www.floragrowth.com |
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
Flora Growth Corp. Fundamentals Summary
| 7301 fundamental statistics | |
|---|---|
| Market cap | €15.18m |
| Earnings (TTM) | -€12.07m |
| Revenue (TTM) | €61.80m |
0.3x
P/S Ratio-1.3x
P/E RatioIs 7301 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7301 income statement (TTM) | |
|---|---|
| Revenue | US$69.01m |
| Cost of Revenue | US$53.55m |
| Gross Profit | US$15.45m |
| Other Expenses | US$28.93m |
| Earnings | -US$13.48m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.01 |
| Gross Margin | 22.39% |
| Net Profit Margin | -19.53% |
| Debt/Equity Ratio | 29.2% |
How did 7301 perform over the long term?
See historical performance and comparison